On October 27, 2023, the International Generics and Biosimilars Medicines Association (IGBA), including members of IGBA’s CEO Advisory Committee, met with World Health Organization (WHO) Director-General Dr. Tedros Adhanom Ghebreyesus in Geneva. During the full-day meeting, IGBA company and member association representatives, together with WHO technical experts, discussed steps both organizations can take together to expand global access to generic and biosimilar medicines.
